International

Latest international events, highlights, advancements and treatments on mesothelioma. Stay one step ahead of the disease. Get informed.

Australia | International | Mesothelioma | New Studies | Prognosis | Research | Statistics | Updates

What We Can Learn from Mesothelioma Trends in Australia
ByAlex Strauss December 30, 2015March 16, 2017

New data out of Australia is revealing some important trends in the incidence and survivability of malignant mesothelioma. The good…

Read More What We Can Learn from Mesothelioma Trends in Australia
Asbestos | Europe | International | New Studies | Research | Statistics | Updates

Mesothelioma Risk is Higher Near Natural Asbestos
ByAlex Strauss December 27, 2015March 16, 2017

There is more evidence that where you live affects your risk of contracting deadly malignant mesothelioma. A recent study conducted…

Read More Mesothelioma Risk is Higher Near Natural Asbestos
Asbestos | Biomarkers | Chemotherapy | Diagnosis | Europe | International | Prognosis | Treatments | Updates

Biomarkers for Mesothelioma Diagnosis and Prognosis
ByAlex Strauss December 15, 2015March 16, 2017

Identifying mesothelioma biomarkers may be the key to diagnosing the asbestos cancer earlier and determining the most effective mesothelioma treatments.…

Read More Biomarkers for Mesothelioma Diagnosis and Prognosis
Europe | International | Prognosis | Statistics | Surgery | Treatments | Updates

Mesothelioma Survival with Conservative Surgery
ByAlex Strauss December 11, 2015March 16, 2017

Yet another new study appears to support the idea that lung sparing pleurectomy/decortication surgery should be the preferred surgical approach…

Read More Mesothelioma Survival with Conservative Surgery
Europe | International | Multi-Modality Therapy | Surgery | Treatments | Updates

Mesothelioma Treatment Outcomes in a Low Volume Center
ByAlex Strauss December 9, 2015March 16, 2017

Is it safe to have cytoreductive surgery and intraoperative chemotherapy for mesothelioma in a center that does not do a…

Read More Mesothelioma Treatment Outcomes in a Low Volume Center
Canada | Immune Systems | Immunotherapy | International | New Drugs | Research | Treatments | Updates

Mesothelioma Community Hopeful About Newly Approved Immunotherapy Drug
ByAlex Strauss December 6, 2015March 16, 2017

Mesothelioma experts around the world are expressing excitement about the potential of the recently FDA-approved cancer drug Keytruda (pembrolizumab). The latest…

Read More Mesothelioma Community Hopeful About Newly Approved Immunotherapy Drug
Canada | International | Multi-Modality Therapy | New Studies | Radiation Therapy | Research | Surgery | Treatments | Updates

New Mesothelioma Treatment Approach Improving Survival
ByAlex Strauss November 30, 2015March 16, 2017

A new treatment protocol for malignant pleural mesothelioma has yielded what Canadian doctors are calling “encouraging” survival results. The approach…

Read More New Mesothelioma Treatment Approach Improving Survival
Asbestos | Asia | Biopsy | Diagnosis | International | Mesothelioma | Occupations | Scans | Updates

The Challenge of Diagnosing Malignant Mesothelioma
ByAlex Strauss November 27, 2015March 16, 2017

The case of a Japanese man whose mesothelioma went undetected until it claimed his life seven months later highlights the…

Read More The Challenge of Diagnosing Malignant Mesothelioma
Europe | International | Multi-Modality Therapy | New Studies | Prognosis | Research | Surgery | Treatments | Updates

Second Surgery May Prolong Mesothelioma Survival
ByAlex Strauss November 24, 2015March 16, 2017

There is new evidence that surgery may be the most effective type of second-line treatment for malignant pleural mesothelioma. First-line…

Read More Second Surgery May Prolong Mesothelioma Survival
Asia | International | Mesothelioma | Multi-Modality Therapy | New Studies | Radiation Therapy | Research | Surgery | Treatments | Updates

Trimodal Mesothelioma Treatment May Not Be Worth the Risk
ByAlex Strauss November 20, 2015March 26, 2019

Japanese researchers say trimodality treatment for mesothelioma that includes chemotherapy, extrapleural pneumonectomy (EPP), and post-surgical radiation may not be beneficial enough…

Read More Trimodal Mesothelioma Treatment May Not Be Worth the Risk

1 (888) 378-1331

International

What We Can Learn from Mesothelioma Trends in Australia

Mesothelioma Risk is Higher Near Natural Asbestos

Biomarkers for Mesothelioma Diagnosis and Prognosis

Mesothelioma Survival with Conservative Surgery

Mesothelioma Treatment Outcomes in a Low Volume Center

Mesothelioma Community Hopeful About Newly Approved Immunotherapy Drug

New Mesothelioma Treatment Approach Improving Survival

The Challenge of Diagnosing Malignant Mesothelioma

Second Surgery May Prolong Mesothelioma Survival

Trimodal Mesothelioma Treatment May Not Be Worth the Risk

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES